Home Ping An Good Doctor and Medtronic Forge Strategic Partnership at CIIE to Advance Digital Health Integration

Ping An Good Doctor and Medtronic Forge Strategic Partnership at CIIE to Advance Digital Health Integration

Nov 07, 2025 19:16 CST Updated 19:16
PINGAN GOOD DOCTOR

Internet Medical Health Platform

Medtronic

Medical Device Manufacturer

On November 7, 2025, in Shanghai, at the 8th China International Import Expo (hereinafter referred to as "CIIE"), Ping An Healthcare Internet Co., Ltd. (hereinafter referred to as "Ping An Good Doctor") and Medtronic (Shanghai) Management Co., Ltd. (hereinafter referred to as "Medtronic") officially announced a strategic partnership. The two parties will integrate their strengths in medical technology and digital health services to jointly build "full life cycle digital health services" and "medical-device-insurance integrated protection" dual closed loops, providing Chinese patients with more accessible, affordable, and efficient health management solutions while actively supporting the implementation of the "Healthy China 2030" strategy.


图片 1.png

From left to right: Ms. Min Zhong, Vice President of Medtronic, Chief Medical Officer of Greater China, and Head of Clinical Research and Medical Science; Ms. Shan Cao, Vice President of Medtronic and Head of Corporate Affairs and Communications; Mr. Quan Zhou, Vice President of Strategy, Industrial Cooperation, and Digital Innovation for Medtronic Greater China; Mr. Yushao Gu, Senior Vice President of Medtronic Global and President of Medtronic Greater China; Mr. Mingke He, Chief Executive Officer of PINGAN GOOD DOCTOR; Mr. Jun Zhang, General Manager of Medical Operations at PINGAN GOOD DOCTOR; Mr. Jieke Hou, Senior Vice President of PINGAN GOOD DOCTOR.

 

Medicine + AI, Providing New Ideas for Health Management


Currently, the world is in an era of continuously upgrading health demands, and China's health landscape is undergoing a profound digital transformation. In 2019, the State Council issued the "Opinions on Implementing the Healthy China Action," establishing specific "roadmaps" and "blueprints" for the construction of Healthy China, putting the principle of prevention first and attention to health influencing factors into practice. In October 2025, six departments, including the National Health Commission, jointly released the "Guiding Opinions on Strengthening Grassroots Chronic Disease Health Management Services," explicitly requiring the integration of comprehensive health management services covering "prevention, screening, diagnosis, treatment, management, and rehabilitation." The health management awareness of the general public has also evolved from "access to medical care" to "quality medical care," and further towards "disease prevention and effective disease management."

Currently, how to advance the prevention and control of diseases and improve the efficiency of health management has become a highly concerning topic for the entire society. The "Implementation Opinions on Promoting and Regulating the Application and Development of 'Artificial Intelligence + Medical Health'" previously issued by the National Health Commission and other departments also emphasized the deepening of artificial intelligence applications in scenarios such as chronic disease management, pointing out the direction for the integration and innovation of "Medicine + AI." The rise of AI has also provided new ideas for health management. It can be seen that AI is extending health management services from single medical segments to multiple fields such as disease prevention, risk warnings, and lifestyle interventions, driving health management to shift from "passive response" to "proactive protection."


It is reported that PINGAN GOOD DOCTOR, after more than a decade of deep cultivation in the medical and health ecosystem, has always been sensitive to new technologies and continuously worked on developing, exploring, and enhancing medical AI technology and its applications. Through in-depth learning of massive databases of medical professional knowledge, medical consultation records, and electronic medical records, Ping An has established six major medical databases, covering 37,000 diseases, 220,000 drug instructions, 2 million classic cases, 30 million medical documents, and 1.44 billion consultations, forming rich and unique professional data. Using its self-developed "Ping An Yi Bo Tong" multimodal large model, PINGAN GOOD DOCTOR can provide users with more precise, personalized, one-stop, and empathetic medical and health services across various scenarios. Among these, based on its newly launched "7+N+1" medical AI product system, the company innovatively introduced a Complex Disease MDT (Multidisciplinary Consultation) Assistance Platform, which has already been applied in breast cancer treatment. It provides comprehensive diagnostic and treatment assistance throughout the treatment and rehabilitation process, significantly improving the efficiency and experience of seeking medical care for complex diseases.

 

Powerful Combination to Explore New Integration of "Medical-Device-Insurance"


In response to the multiple challenges still faced in China's healthcare sector, such as insufficient service accessibility and lack of continuity, the collaboration between PINGAN GOOD DOCTOR and Medtronic represents a precisely matched partnership that leverages complementary strengths. As the flagship member of Ping An Group's extensive healthcare ecosystem and the first internet healthcare service platform from mainland China listed on the Hong Kong Stock Exchange, PINGAN GOOD DOCTOR has, in recent years, relied on its closed-loop advantage of "Data + Models + Scenarios." By developing two core hubs and entry points—the "Family Doctor" and "Elder Care Manager"—the company is committed to providing users with proactive, one-stop, and implementable health management services throughout their entire life cycle. Medtronic, with over three decades of deep engagement in China, possesses substantial clinical expertise and cutting-edge technological products in areas such as chronic disease management and cardiovascular care. Reportedly, the two parties will focus their cooperation on the following two key aspects:


First, complementary advantages empower digital services. PINGAN GOOD DOCTOR will introduce Medtronic's professional medical maps and clinical program design capabilities in the fields of chronic disease management and cardiovascular care to further enhance our precision and user satisfaction in related disease management, diagnosis and treatment, medication, and rehabilitation. At the same time, relying on our Ping An Family Doctor team and digital platform, we will break down the barriers between "in-hospital treatment" and "out-of-hospital management" to achieve full-process digital health management from prevention, diagnosis, intervention to long-term follow-up.


Second, explore innovative models to reduce the burden on patients. PINGAN GOOD DOCTOR will fully leverage its platform's role as a "service amplifier" and "user connector." With extensive user reach and an efficient operational system, it will help Medtronic's innovative medical technology break through limitations of time, space, and information, providing more precise and accessible services to a broader audience. Together, they will explore an innovative model that integrates "medical-device-insurance," creating more flexible payment solutions to alleviate patient burdens, allowing high-quality healthcare and cutting-edge technology to truly reach ordinary households.


PINGAN GOOD DOCTOR CEO He Mingke stated, "We not only provide health insurance coverage but also safeguard every individual's entire life journey. With an open mind and a pragmatic attitude, PINGAN GOOD DOCTOR will carry out comprehensive, systematic, and continuous cooperation with Medtronic. We look forward to joining hands to continuously advance this partnership, striving to make it an industry model for the integration of innovative digital healthcare and traditional professional medical care."


图片 2.png

PINGAN GOOD DOCTOR CEO He Mingke

 

Medtronic Global Senior Vice President and Greater China President, Gu Yushao, stated: "We have always believed that leveraging massive data and artificial intelligence technology can drive the medical industry towards precision and efficiency. This is particularly evident throughout the entire life cycle of chronic disease management and treatment, where patient benefits can be maximized, societal healthcare burdens reduced, and medical insurance and commercial insurance resource allocation optimized, ultimately building a value-driven health service ecosystem loop. We highly anticipate this cooperation to become the starting point of deep synergy between both parties. Moving forward, we will jointly explore more innovative possibilities and promote high-quality, sustainable development in the healthcare industry."


图片 3.png

Medtronic Global Senior Vice President and Greater China President Gu Yushao

 

Medtronic Vice President Zhong Min stated that solving the core pain points in the healthcare field cannot be achieved by the strength of a single company alone. Medtronic looks forward to collaborating with PINGAN GOOD DOCTOR, hoping that the combination of Medtronic's clinical expertise and PINGAN GOOD DOCTOR’s platform service capabilities will allow high-quality medical resources to reach patients in need more broadly and accurately. This is an important step for Medtronic in fulfilling its mission to "alleviate pain, restore health, and extend life."


图片 4.png

Medtronic Vice President Zhong Min

 

This strategic collaboration between PINGAN GOOD DOCTOR and Medtronic marks a milestone, signifying that healthcare management services are entering a new phase of deep integration between "professional medicine + digital platforms." Looking ahead, the two parties will drive the implementation of their cooperation with strong execution, providing an innovative approach to addressing issues such as uneven medical resources and fragmented services, while jointly contributing sustainable corporate value to the construction of "Healthy China."